INSIGHTS

Shadow Counsels (SC) are not a concept popularly exploited in India. However, their potential is yet to be discovered and realized in...

Applicability of order XIII-A of CPC to Intellectual Property Dispute With the objective of streamlining and expediting the disposal of...

Xtandi, the wonder drug for prostate cancer, was developed at UCLA, Los Angeles, by the innovation of NIH and Department of Defense...

Introduction: It always has been a well known fact that the markets in India are targeted by large number of counterfeit products/goods....

In the case of Bayer Corporation versus Union of India & ors (W.P.(C) 1971/2014) and Bayer Intellectual Property Gmbh & Anr versus...

Shireen Shukla, legal intern at Kkurana & Khurana , probes the recent International IP Index report, released by U.S. Chamber of...

Union budget that was highly waited for (after demonetization) had gained more attention also due to preponing to February 01, 2017. As a...

Different countries having regard to National Security Considerations and with the intent of having a check on the defence and atomic...

In Roxane Laboratories, Inc. (hereinafter referred to be as “Roxane”) v. Camber Pharmaceuticals Inc., et al. (hereinafter referred to as...

Lee Pharma, a Hyderabad-based Indian pharma company, has filed a Compulsory Licensing (CL) Application (in accordance with Section 84(1)...

Patent Litigation in India has steadily increased over the last 2-3 years. Dramatic swift has been observed in the innovator’s...

Reportedly, Hon’ble Supreme Court of India on Special Leave Petition filed by Glenmark stayed the Delhi High Court order which passed...

Recently, the Delhi high court on dated 30 th January 2015 set aside an order of the Deputy Controller of Patents and Designs. The...

Reportedly, a bench of Delhi High Court temporarily allowed Xiaomi to sell few of its devices in India about a week after the suspension...

In a latest update, Novartis has sued Cipla for infringing its patents on “Onbrez” (Indacaterol) after Cipla lunched its generic version...

As reported in TOI , the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for...

In CS(OS)  3775/2014, as we understand from multiple sources, Xiaomi has been injuncted from manufacturing its line of smart phones for...

It has been recently reported in Economic times that Cipla has filed representation with the government (Department of Industrial Policy...

We have earlier reported the release of Draft Guidelines for Examination of Pharma Patent Applications. The Patent office has now...

With a significantly increasing number of Individual Inventors and Small/Medium Sized Clients regularly asking on Patent Registration...